AP2015008270A0 - Preparation for the treatment of tuberculosis - Google Patents

Preparation for the treatment of tuberculosis

Info

Publication number
AP2015008270A0
AP2015008270A0 AP2015008270A AP2015008270A AP2015008270A0 AP 2015008270 A0 AP2015008270 A0 AP 2015008270A0 AP 2015008270 A AP2015008270 A AP 2015008270A AP 2015008270 A AP2015008270 A AP 2015008270A AP 2015008270 A0 AP2015008270 A0 AP 2015008270A0
Authority
AP
ARIPO
Prior art keywords
tuberculosis
preparation
treatment
Prior art date
Application number
AP2015008270A
Inventor
Mykola Ivanovych Gumeniuk
Original Assignee
Mykola Ivanovych Gumeniuk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mykola Ivanovych Gumeniuk filed Critical Mykola Ivanovych Gumeniuk
Publication of AP2015008270A0 publication Critical patent/AP2015008270A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
AP2015008270A 2012-07-20 2013-07-22 Preparation for the treatment of tuberculosis AP2015008270A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
UA201208962 2012-07-20
PCT/UA2013/000079 WO2014014434A1 (en) 2012-07-20 2013-07-22 Preparation for the treatment of tuberculosis

Publications (1)

Publication Number Publication Date
AP2015008270A0 true AP2015008270A0 (en) 2015-02-28

Family

ID=56889302

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2015008270A AP2015008270A0 (en) 2012-07-20 2013-07-22 Preparation for the treatment of tuberculosis

Country Status (6)

Country Link
AP (1) AP2015008270A0 (en)
BR (1) BR112015001275A2 (en)
EA (1) EA025861B1 (en)
RU (1) RU2648822C2 (en)
UA (1) UA74095U (en)
WO (1) WO2014014434A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495534B2 (en) * 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
CN102458421A (en) * 2009-05-28 2012-05-16 欧布谢斯特沃公司 Medicinal agent

Also Published As

Publication number Publication date
UA74095U (en) 2012-10-10
BR112015001275A2 (en) 2018-01-30
RU2648822C2 (en) 2018-03-28
EA201590243A1 (en) 2015-06-30
RU2015106366A (en) 2016-09-10
WO2014014434A1 (en) 2014-01-23
EA025861B1 (en) 2017-02-28

Similar Documents

Publication Publication Date Title
EP2906208A4 (en) Therapeutic treatment
EP2867209A4 (en) Compounds and therapeutic uses thereof
HK1211480A1 (en) External preparation for skin
SI2812013T1 (en) Formulation for the treatment of ibs
ZA201504167B (en) Processes for the preparation of 4-amino-3-halo-6- (substituted)picolinates and 4-amino-5-fluoro-3-halo-6- (substituted)picolinates
IL236450A (en) Process for the preparation of 5-fluoro-1h-pyrazoles
PL399418A1 (en) Process for the preparation of 4-methoxydihydrochalcone
PL399419A1 (en) Process for the preparation of 4-methoxydihydrochalcone
ZA201501038B (en) Treatment of wax
IL234796B (en) Compounds for the treatment of ischemia-reperfusion-related diseases
EP2804853A4 (en) Therapeutic uses
GB201207907D0 (en) Treatment of depression
AP2015008270A0 (en) Preparation for the treatment of tuberculosis
HK1210421A1 (en) Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders -4--20--3-
IL236873A0 (en) Therapeutic compounds
HUP1200675A2 (en) Process for the preparation of pyrimidinyl-piperazines
GB201221118D0 (en) Methods of treatment
GB201216740D0 (en) Methods of treatment
GB201216748D0 (en) Methods of treatment
GB201206326D0 (en) Methods of treatment
GB201206324D0 (en) Methods of treatment
GB201206330D0 (en) Methods of treatment
GB201206325D0 (en) Methods of treatment
GB201211135D0 (en) Treatment
GB201208690D0 (en) Treatment